Research Summary
This animal model study investigated a polydopamine-based delivery system designed to transport nicotinamide mononucleotide (NMN) across the blood-brain barrier and increase NAD+ levels in brain tissue. The researchers developed and tested this biocompatible nanoplatform in animal models and found that the delivery system successfully enhanced NAD+ accumulation in the brain compared to unformulated NMN. This work represents early-stage research demonstrating a potential mechanism for improving brain bioavailability of NMN through nanotechnology-based delivery approaches.